A drug that can help prevent migraines could soon be available on the NHS. Atogepant (brand name: Aquipta) was recently recommended by the National Institute for Health and Care Excellence (NICE) to prevent episodic and chronic migraine attacks.
Migraine sufferers in England may soon be able to access a preventative drug: Atogepant retrieved 23 April 2024 from https://medicalxpress.com/news/2024-04-migraine-england-access-drug-atogepant.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Migraine pill which could help 170,000 sufferers given NHS green lightThe health minister says the treatment could give those with the condition a chance to 'live their life to the fullest'.
Baca lebih lajut »
Daily migraine pill gets green light on NHS for 170,000 BritsWhy you’re suffering from a migraine and how to prevent it
Baca lebih lajut »
Daily migraine pill which could help 170,000 sufferers gets NHS go-aheadThe daily treatment will be an option for people who have at least four migraine days a month
Baca lebih lajut »
Daily Pill to Halve Migraine Frequency Offered on NHSMigraine sufferers in England will be offered a daily pill on the NHS that can reduce the frequency of debilitating headaches. The National Institute for Health and Care Excellence (Nice) has recommended the use of Atogepant, a once-daily medicine, for the first time, providing more treatment options for around 170,000 patients. The pill will be available for those who experience at least four migraine days a month and have tried three other treatments without success.
Baca lebih lajut »
Migraine breakthrough as new pill offered on NHS for the first timeAtogepant – sold under the brand name Aquipta and made by AbbVie – has been given the green light for NHS
Baca lebih lajut »
A New Migraine Drug Is Coming To England, Here’s How To Get ItAtogepant wil be the first oral treatment for chronic and episodic migraines.
Baca lebih lajut »